Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Current Assets (2022 - 2026)

HeartSciences' Current Assets history spans 5 years, with the latest figure at $5.1 million for Q1 2026.

  • For Q1 2026, Current Assets rose 40.5% year-over-year to $5.1 million; the TTM value through Jan 2026 reached $5.1 million, up 40.5%, while the annual FY2025 figure was $2.2 million, 70.47% down from the prior year.
  • Current Assets reached $5.1 million in Q1 2026 per HSCS's latest filing, up from $3.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $8.7 million in Q1 2024 to a low of $1.8 million in Q4 2023.
  • Average Current Assets over 5 years is $4.2 million, with a median of $4.0 million recorded in 2022.
  • Peak YoY movement for Current Assets: surged 213.93% in 2024, then tumbled 70.47% in 2025.
  • A 5-year view of Current Assets shows it stood at $4.1 million in 2022, then tumbled by 56.09% to $1.8 million in 2023, then soared by 213.93% to $5.7 million in 2024, then tumbled by 33.32% to $3.8 million in 2025, then skyrocketed by 34.41% to $5.1 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Current Assets are $5.1 million (Q1 2026), $3.8 million (Q4 2025), and $4.4 million (Q3 2025).